PHR: Koefisien utang jangka dawa marang modal Phreesia, Inc.

Lambang korporat lan logo Phreesia, Inc. (PHR)

Through its SaaS model, Phreesia, Inc. (PHR) ensures seamless IT infrastructure operations without logistical disruptions. This chart of the market value demonstrates the dynamics of the company, whose metrics, including debt load, stand at 0.18. Profit growth relies on transaction volume and cost management efficiency. However, clinic conservatism, data breach threats, and fierce sector competition could slow business expansion.

Utang jangka dawa marang modal: Phreesia, Inc. (PHR) kanggo 04.07.2022 - 29.10.2026
Sampel barang Phreesia Health

The selection of the issuer is based on an analysis of the capital structure, where the ratio of long-term liabilities to equity determines the business's level of financial autonomy. This long-term debt financial leverage metric on GURU.Markets measures the dependence of Phreesia, Inc. (PHR) on external borrowing when scaling its cloud IT infrastructure, allowing the investor to assess the funding stability for the continuous updating of patient registration services.

Analisis perusahaan pesaing

VEEV (Veeva Systems) - Rasio silihan jangka dawa marang modal|Rasio utang jangka dawa marang ekuitas DOCS (Doximity Corp)|HQY (HealthEquity Building) - Koefisien utang jangka dawa marang modal|Utang jangka dawa marang ekuitas Waystar Holding Corp. WAY|CRVL - Rasio utang jangka dawa marang ekuitas|Privia Health - Utang jangka dawa marang modal|Kewajiban jangka dawa marang modal Huron Consulting Group Inc.|CERT: Utang jangka dawa marang modal|Rasio utang jangka dawa marang modal OMCL|Utang jangka dawa marang ekuitas GoodRx Holdings, Inc.|schrodinger.com - Kewajiban jangka dawa marang ekuitas|Utang jangka dawa marang modal OMDA|EVH (Evolent Health Inc) - Koefisien utang jangka dawa marang modal|Utang jangka dawa marang ekuitas HealthStream Corp HSTM|Koefisien utang jangka dawa marang modal DH|Consensus Cloud Solutions - Utang jangka dawa marang modal|Kewajiban jangka dawa marang modal agilonhealth.com|ABSI: Utang jangka dawa marang modal|Kewajiban jangka dawa marang modal So-Young International Inc (SY)|Utang jangka dawa marang ekuitas National Research|USA Mobility (SPOK) - Rasio tanggungan utang jangka dawa marang modal|Utang jangka dawa marang modal OPRX|Rasio tanggungan utang jangka dawa marang modal trubridge.com|Utang jangka dawa marang modal SLP (Simulations Plus)|Utang jangka dawa marang modal Sophia Genetics SOPH|HCAT: Rasio utang jangka dawa marang ekuitas|Koefisien utang jangka dawa marang modal CCLD (CareCloud, Inc.)|RSSS: Utang jangka dawa marang modal|DLHC - Rasio tanggungan utang jangka dawa marang modal|Utang jangka dawa marang ekuitas OneMedNet Corp|Rasio utang jangka dawa marang modal SCNX (Scienture Holdings)|Utang jangka dawa marang modal HCTI|Rasio utang jangka dawa marang ekuitas ispecimen.com ISPC|Bullfrog AI - Rasio utang jangka dawa marang ekuitas|Rasio tanggungan utang jangka dawa marang modal scworx.com (WORX)|MSPR - Utang jangka dawa marang ekuitas|Kewajiban jangka dawa marang ekuitas ICCT|MEDS: Utang jangka dawa marang modal|Orgenesis Corporation - Koefisien utang jangka dawa marang modal|Utang jangka dawa marang ekuitas R1 RCM, Inc.|SHCR: Koefisien utang jangka dawa marang modal|Utang jangka dawa marang modal STRM|Rasio tanggungan utang jangka dawa marang modal Syra Health Corp|Apollo Medical Holdings, Inc. - Rasio utang jangka dawa marang ekuitas|Rasio silihan jangka dawa marang modal MODN (Model N Corporation)|NXGN: Rasio utang jangka dawa marang ekuitas